SET SMS ALERT
BSE
Dec 12, 09:08
Dec 12, 09:08
2443.00
-0.70 (-0.03%)
High
2443.00
Low
2443.00
High
2422.00
Low
2372.00
|
|
| 5-Day | 10,425 |
| 10-Day | 13,874 |
| 30-Day | 18,483 |
| 5-Day | 10,425 |
| 10-Day | 13,874 |
| 30-Day | 18,483 |
| 5-Day | 231,109 |
| 10-Day | 235,810 |
| 30-Day | 281,139 |
| 5-Day | 231,109 |
| 10-Day | 235,810 |
| 30-Day | 281,139 |
| NSE SERIES | LAST PRICE | CHANGE(%) | OPEN | HIGH | LOW | FACE VALUE |
|---|---|---|---|---|---|---|
| N1 | 5.30 | 0.19% | 5.28 | 5.30 | 5.28 | 5 |
| Days | BSE | NSE |
| 30 | 2446.48 | 2447.74 |
| 50 | 2431.18 | 2432.08 |
| 150 | 2280.57 | 2281.06 |
| 200 | 2175.12 | 2175.73 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Dr Reddys Labs
| Consolidated | (Sep '13) Quarterly |
(Mar '13) Yearly |
| Net Sales | 3357.45 | 11626.56 |
| Other Income | 63.67 | 247.90 |
| PBDIT | 736.01 | 2111.23 |
| Net Profit | 690.25 | 1677.62 |
| Total Share Capital | 84.90 |
| Net Worth | 7783.40 |
| Total Debt | 1589.10 |
| Net Block | 2387.00 |
| Investments | 2379.20 |
| Net Current Assets | 4183.10 |
| Total Assets | 9372.50 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 575.35 | -1.47 | 650.00 | 357.50 | 119,164.42 |
| Dr Reddys Labs | 2403.75 | -1.63 | 2545.00 | 1764.00 | 40,887.72 |
| Lupin | 877.40 | 0.22 | 946.35 | 598.00 | 39,323.13 |
| Cipla | 381.10 | -1.65 | 450.00 | 370.95 | 30,599.33 |
| GlaxoSmithKline | 2441.70 | -0.86 | 2899.00 | 2005.00 | 20,681.94 |
| More » | |||||
| Sep' 13 | Jun' 13 | Mar' 13 | Dec' 12 | |
| Promoter | 25.52 | 25.53 | 25.56 | 25.56 |
| FII | 32.56 | 32.69 | 29.66 | 26.17 |
| DII | 8.88 | 8.84 | 11.03 | 13.98 |
| Others | 33.04 | 32.94 | 33.75 | 34.29 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| Franklin India Bluechip Fund (G) | 824,546 |
| DSP BlackRock Top 100 Equity Fund - Regular Plan (G) | 610,510 |
| ICICI Prudential Focused Bluechip Equity Fund (G) | 520,359 |
| HDFC Top 200 Fund (G) | 487,749 |
Dr Reddys Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 40,887.72 crore.The company has reported a consolidated sales of Rs 3357.45 crore and a Net Profit of Rs 690.25 crore for the quarter ended Sep 2013.
The company management includes G V Prasad - Chairman & CEO, Satish Reddy - Vice Chairman & Mng.Director, Anupam Puri - Independent Director, Ashok S Ganguly - Independent Director, Bruce L A Carter - Independent Director, J P Moreau - Independent Director, Kalpana Morparia - Independent Director, Omkar Goswami - Independent Director, Ravi Bhoothalingam - Independent Director, Sridar Iyengar - Independent Director.
It is listed on the BSE with a BSE Code of 500124 and the NSE with an NSE Code of DRREDDY.
Its Registered office is at 8-2-337, Road No. 3,,Banjara Hills Hyderabad,Andhra Pradesh - 500034.
Their Registrars are Bigshare Services Pvt. Ltd.